Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2025.
Financials
Financial year 2025
HOMEOPHARMA from Anderlecht, company number BE0767692543, closed financial year 2025 with a result of € -5,096 after tax. For that financial year HOMEOPHARMA recorded a gross margin of € -1,064 and equity of € 6,000. Compared with financial year 2023, the result moved from € -30,837 to € -5,096. The company made a loss. The buffer shrank hard: equity is 56 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.
€ 6,000
▼ 56% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5,096
▲ 83 % less loss than in 2023
Profit after tax over the fiscal year.
€ 10,516
▼ 72% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 3,000.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 245
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 52,000 | € -24,405 | € -1,064 | ▲ € 23,341 |
| Profit after taxes | € 41,568 | € -30,837 | € -5,096 | ▲ € 25,741 |
| Equity | € 44,568 | € 13,732 | € 6,000 | ▼ 56% |
| Total debts | € 13,693 | € 23,399 | € 4,516 | ▼ 81% |
| Cash | € 48,261 | € 37,130 | € 10,516 | ▼ 72% |
| Retained profit | € 41,568 | € 10,732 | € 3,000 | ▼ 72% |
| Balance sheet total | € 58,261 | € 37,130 | € 10,516 | ▼ 72% |
Key figures of HOMEOPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
Ask about HOMEOPHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to HOMEOPHARMA?
What happened at HOMEOPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 5,096. Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 41,568 profit in 2022 to € 5,096 loss in 2025.
Paid € 13,183 in corporate taxes since 2022.
Best year ever: 2022, with € 41,568 profit.
Management
Behind HOMEOPHARMA are Salim Makori and Adil Chellai. The same people are also behind PHARMACIE APPART. Adil Chellai is also behind A.C. PHARMA and AC BIZET.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Doverstraat 132-134
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0767.692.543
- VAT number
- BE 0767.692.543
- Registered office
- Doverstraat 132-134, 1070 Anderlecht
- Names & denominations
- HOMEOPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 April 2021
- Peppol
- Active · Active since 4 Dec 2025